The provided chart depicts the proportion of pharmaceutical company’s total deals, by region, over the period of 2002 to 2006.
At the first glance, it is immediately obvious that Asia has observed significant growth. In contrast, Europe and America faced a considerable decrease after fluctuating noticeably
In the first year, Asia accounted for a quarter of the company’s sales, which was the lowest one. This region registered a notable ascending trend, with its figure peak at 40%, surpassing America for the leading position at the end of the period.
Meanwhile, America topped the list with a ratio of 41 at the start of the period. This number plummeted dramatically to 27% in 2004 and recovered steeply afterward to 30% at the end of the given period. Europe also witnessed a similar downward trend despite being in first place in 2004 with the figure standing at 38%.
